Table 6. Malignancy risk for different Milan categories as reported in different contemporary studies and their comparison with the present study.
| Milan Category | Malignancy risk % | ||||
| Amita et al. [13] | Rohilla et al. [14] | Karuna et al. [15] | Bharti et al. [16] | Present study | |
| I (Inadequate) | 0 | 0 | 0 | 0 | 0 |
| II (Non-neoplastic) | 6.3 | 17.4 | 0 | 0 | 0 |
| III (Atypia of undetermined significance) | 100 | 100 | 50 | 100 | 100 |
| IVa (Neoplastic benign) | 0 | 7.3 | 2.44 | 5.3 | 24 |
| IVb (Neoplastic uncertain malignant potential) | 25 | 50 | 33.3 | 33.0 | 50 |
| V (Suspicious) | 100 | 0 | 100 | 0 | 80 |
| VI (Malignant) | 100 | 96 | 93.3 | 80 | 84.6 |